Announcements
- 2023.08.16 DATE OF BOARD MEETING
- 2023.08.07 VOLUNTARY ANNOUNCEMENT COMPLETION OF THE FIRST FEE-FOR-SERVICE COMPASSIONATE USE TREATMENT WITH LUX-VALVE PLUS IN THE ASIA-PACIFIC REGION
- 2023.08.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
- 2023.08.01 Articles of Association
- 2023.07.07 EARLY FEASIBILITY STUDY OF LUX-VALVE PLUS PRE-SUBMISSION ACCEPTED BY THE FDA
- 2023.07.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
- 2023.06.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
- 2023.05.31 POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON MAY 31, 2023
- 2023.05.16 POLL RESULTS OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING, THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS AND THE 2023 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS AND UNLISTED FOREIGN SHAREHOLDERS
- 2023.05.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
